Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


Articles published in AIDS Res Hum Retroviruses

Retrieve available abstracts of 252 articles:
HTML format



Single Articles


    September 2022
  1. RUIZ-MANRIQUEZ CA, Hernandez-Ruiz VA, Crabtree-Ramirez BE, Amieva H, et al
    A lower CD4+/CD8+ ratio predicts activities of daily living decline among older adults with HIV.
    AIDS Res Hum Retroviruses. 2022 Sep 22. doi: 10.1089/AID.2022.0080.
    PubMed     Abstract available


  2. RIPAMONTI D, Poliseno M, Mazzola G, Colletti P, et al
    Perceptions of U=U among Italian Infectious Diseases Specialists: a nationwide survey on providers' attitudes towards the risk of HIV transmission in virologically suppressed patients.
    AIDS Res Hum Retroviruses. 2022 Sep 13. doi: 10.1089/AID.2022.0056.
    PubMed     Abstract available


  3. LANTZ A, Nicol MR
    Translational Models to Predict Target Concentrations for Pre-Exposure Prophylaxis in Women.
    AIDS Res Hum Retroviruses. 2022 Sep 13. doi: 10.1089/AID.2022.0057.
    PubMed     Abstract available


    August 2022
  4. NEERGAARD R, Jones NL, Roebuck C, Rendle KA, et al
    "I know that I was a part of making a difference": Participant motivations for joining a cure-directed HIV trial with an analytical treatment interruption.
    AIDS Res Hum Retroviruses. 2022 Aug 18. doi: 10.1089/AID.2022.0040.
    PubMed     Abstract available


  5. YEAGER S, Montoya JL, Burke L, Chow K, et al
    Patient and physician preferences regarding long-acting pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART): A mixed-methods study in Southern California, USA.
    AIDS Res Hum Retroviruses. 2022 Aug 16. doi: 10.1089/AID.2022.0029.
    PubMed     Abstract available


  6. DUBE K, Agarwal H, Stockman JK, Auerbach JD, et al
    "I would absolutely need to know that my partner is still going to be protected": Perceptions of HIV Cure-Related Research among Diverse HIV Serodifferent Couples in the United States.
    AIDS Res Hum Retroviruses. 2022 Aug 16. doi: 10.1089/AID.2022.0036.
    PubMed     Abstract available


  7. WANG X, Chen M, Ma S, Ding Y, et al
    HIV-1 Tat protein-mediated inflammatory response inhibits the erythroid hematopoietic support function of bone marrow mesenchymal stem cells.
    AIDS Res Hum Retroviruses. 2022 Aug 16. doi: 10.1089/AID.2022.0011.
    PubMed     Abstract available


  8. HERNANDEZ-RUIZ VA, Erlandson KM, Amieva H, Avila-Funes JA, et al
    VACS index and Frailty: one part of the whole.
    AIDS Res Hum Retroviruses. 2022 Aug 16. doi: 10.1089/AID.2022.0075.
    PubMed     Abstract available


  9. WEERASURIA M, Ko C, Ehm A, O'Bryan J, et al
    The impact of the COVID-19 pandemic on people with HIV in Victoria, Australia: 1 year later.
    AIDS Res Hum Retroviruses. 2022 Aug 16. doi: 10.1089/AID.2022.0048.
    PubMed     Abstract available


  10. YU D, Liang B, Yang Y, Liu J, et al
    Prevalence of drug resistance and genetic transmission networks among HIV/AIDS patients with antiretroviral therapy failure in Guangxi, China.
    AIDS Res Hum Retroviruses. 2022 Aug 16. doi: 10.1089/AID.2021.0181.
    PubMed     Abstract available


  11. KOUAMOU V, Machekano R, Mapangisana T, Maposhere C, et al
    Tenofovir, Lamivudine and Dolutegravir (TLD) among Rural Adolescents in Zimbabwe, a Cautionary Tale.
    AIDS Res Hum Retroviruses. 2022 Aug 12. doi: 10.1089/AID.2021.0140.
    PubMed     Abstract available


  12. FENG L, Chen T, Zhang J, Wang Q, et al
    Clinical characteristics and outcomes of chronic kidney disease in people living with HIV in a resource limited centre of central China.
    AIDS Res Hum Retroviruses. 2022 Aug 11. doi: 10.1089/AID.2022.0009.
    PubMed     Abstract available


  13. YAGER J, Brooks KM, Brothers J, Mulligan K, et al
    Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate among transgender adolescents and young adults without HIV receiving gender affirming hormones.
    AIDS Res Hum Retroviruses. 2022 Aug 9. doi: 10.1089/AID.2022.0043.
    PubMed     Abstract available


  14. HSU R, Brunet L, Fusco JS, Mounzer K, et al
    Excessive weight gain: current antiretroviral agents in virologically suppressed people with HIV.
    AIDS Res Hum Retroviruses. 2022 Aug 3. doi: 10.1089/AID.2021.0188.
    PubMed     Abstract available


  15. PARMLEY LE, Harris TG, Hakim AJ, Musuka G, et al
    Recent HIV infection among men who have sex with men, transgender women, and genderqueer individuals with newly diagnosed HIV infection in Zimbabwe: Results from a respondent-driven sampling survey.
    AIDS Res Hum Retroviruses. 2022 Aug 3. doi: 10.1089/AID.2021.0216.
    PubMed     Abstract available


    July 2022
  16. LU X, Li Y, Wang Y, An N, et al
    Identification of a new HIV-1 CRF68_01B/CRF01_AE recombinant form among men who have sex with men in Hebei province, China.
    AIDS Res Hum Retroviruses. 2022 Jul 29. doi: 10.1089/AID.2022.0067.
    PubMed     Abstract available


  17. CASSEB J, Lopes LR
    Reflection about the ancient emergence of HTLV-2 infection: Potential for endogenization.
    AIDS Res Hum Retroviruses. 2022 Jul 14. doi: 10.1089/AID.2022.0019.
    PubMed     Abstract available


  18. LANZAFAME M, Rizzardo S, Lattuada E, Luise D, et al
    Dolutegravir monotherapy and weight gain in naive patients with <100,000 copies/ml HIV RNA:an extended follow-up.
    AIDS Res Hum Retroviruses. 2022 Jul 10. doi: 10.1089/AID.2021.0234.
    PubMed     Abstract available


  19. YAGER J, Brooks KM, Brothers J, Mulligan K, et al
    Gender-affirming hormone pharmacokinetics among adolescent and young adult transgender persons receiving daily F/TDF.
    AIDS Res Hum Retroviruses. 2022 Jul 10. doi: 10.1089/AID.2022.0044.
    PubMed     Abstract available


  20. FAN W, Liu Y, Li Y, Su M, et al
    Identi fi cation of Three Novel HIV-1 Second-Generation Recombinant Forms (CRF01_AE/CRF07_BC) Among MSM in Baoding, Hebei, China.
    AIDS Res Hum Retroviruses. 2022 Jul 10. doi: 10.1089/AID.2022.0037.
    PubMed     Abstract available


  21. SIDDIQUI M, Moore TJ, Long DM, Burkholder GA, et al
    Risk factors for incident hypertension within one year of initiating antiretroviral therapy among people with HIV.
    AIDS Res Hum Retroviruses. 2022 Jul 1. doi: 10.1089/AID.2021.0213.
    PubMed     Abstract available


  22. ABIDI SH, Siddiqui D, Mahmood SF, Siddiqui R, et al
    Unassigned complex unique recombinant forms related to CRF36_cpx in children identified in an HIV-1 outbreak in Pakistan.
    AIDS Res Hum Retroviruses. 2022 Jul 1. doi: 10.1089/AID.2021.0168.
    PubMed     Abstract available


  23. BOATENG AT, Abaidoo-Myles A, Bonney EY, Kyei GB, et al
    Isoform selective versus non-selective histone deacetylase inhibitors in HIV latency reversal.
    AIDS Res Hum Retroviruses. 2022 Jul 1. doi: 10.1089/AID.2021.0195.
    PubMed     Abstract available


  24. TOEQUE MG, Lindsay B, Zulu PM, Hachaambwa L, et al
    Treatment-Experienced Patients on Third-Line Therapy: A Retrospective Cohort of Treatment Outcomes at the HIV Advanced Treatment Centre, University Teaching Hospital, Zambia.
    AIDS Res Hum Retroviruses. 2022 Jul 1. doi: 10.1089/AID.2021.0208.
    PubMed     Abstract available


  25. LESSARD D, Dube K, Bilodeau M, Keeler P, et al
    Willingness of older Canadians with HIV to participate in HIV cure research near and after the end-of-life: A mixed-method study.
    AIDS Res Hum Retroviruses. 2022 Jul 1. doi: 10.1089/AID.2022.0006.
    PubMed     Abstract available


    June 2022
  26. ARIYANTO I, Estiasari R, Lee S, Price P, et al
    gammadelta T-cell subpopulations associate with recovery of memory function in Indonesian HIV patients starting ART.
    AIDS Res Hum Retroviruses. 2022 Jun 14. doi: 10.1089/AID.2021.0171.
    PubMed     Abstract available


  27. LIU S, Yan Q, Xiao M, Jiang Y, et al
    The impact of frailty on all-cause mortality in patients with HIV infection: A systematic review and meta-analysis.
    AIDS Res Hum Retroviruses. 2022 Jun 4. doi: 10.1089/AID.2021.0155.
    PubMed     Abstract available



  28. Call for Special Issue Papers: HIV Research Towards a Cure.
    AIDS Res Hum Retroviruses. 2022;38:431-432.
    PubMed    


    May 2022
  29. SHRESTHA I, Ming K, Jimenez V, Wendelborn J, et al
    Lessons learned from an HIV pre-exposure prophylaxis coordination program in San Francisco primary care clinics.
    AIDS Res Hum Retroviruses. 2022 May 20. doi: 10.1089/AID.2022.0013.
    PubMed     Abstract available


  30. DE SCHACHT C, Lucas C, Paulo P, Van Rompaey S, et al
    Reaching males and young adults in a pharmacy-based HIV self-testing strategy: Results from an acceptability study in Mozambique.
    AIDS Res Hum Retroviruses. 2022 May 17. doi: 10.1089/AID.2021.0116.
    PubMed     Abstract available


  31. MALAMA K, Logie CH, Narasimhan M, Ouedraogo L, et al
    Short Communication vertical line Awareness of HIV self-care interventions across global regions: results from a values and preferences survey.
    AIDS Res Hum Retroviruses. 2022 May 17. doi: 10.1089/AID.2021.0200.
    PubMed     Abstract available


  32. SABERI P, Campbell C, Sauceda JA, Ndukwe SO, et al
    Perceptions of risks and benefits of participating in HIV cure-related research among diverse young adults living with HIV in the United States: qualitative research findings.
    AIDS Res Hum Retroviruses. 2022 May 17. doi: 10.1089/AID.2021.0192.
    PubMed     Abstract available


  33. TASHIRO Y, Matsuura E, Sagara Y, Nozuma S, et al
    High Prevalence of HTLV-1 Carriers Among the Elderly Population in Kagoshima, a Highly Endemic Area in Japan.
    AIDS Res Hum Retroviruses. 2022;38:363-369.
    PubMed     Abstract available


    April 2022
  34. CAIRA-CHUQUINEYRA B, Fernandez-Guzman D, Soriano-Moreno DR, Fernandez-Morales J, et al
    Fecal microbiota transplantation for people living with HIV: A scoping review.
    AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2022.0016.
    PubMed     Abstract available


  35. TEDALDI EM, Armon C, Li J, Mahnken J, et al
    A heavy burden: preexisting physical and psychiatric comorbidities, and differential increases among male and female participants after initiating antiretroviral therapy in the HIV Outpatient Study, 2008-2018.
    AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2021.0178.
    PubMed     Abstract available


  36. FERGUSON N, Cogswell A, Barker E
    Contribution of Innate Lymphoid Cells in Supplementing Cytokines Produced by CD4+ T-cells During Acute and Chronic SIV Infection of the Colon.
    AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2022.0007.
    PubMed     Abstract available


  37. NARVAEZ M, Lins-Kusterer L, Valdelamar-Jimenez J, Brites C, et al
    Quality of life and antiretroviral therapy adherence: A cross-sectional study in Colombia.
    AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2021.0233.
    PubMed     Abstract available


  38. NJUHO PM, Haankuku UN
    HIV infection progression monitoring system based on CD4 counts and Wishart-distribution.
    AIDS Res Hum Retroviruses. 2022 Apr 18. doi: 10.1089/AID.2021.0118.
    PubMed     Abstract available


  39. SCHINDLER S, Magalhaes RA, Costa ELF, Brites C, et al
    Genital cytokines in HIV/ human papillomavirus co-infection: a systematic review.
    AIDS Res Hum Retroviruses. 2022 Apr 18. doi: 10.1089/AID.2021.0139.
    PubMed     Abstract available


  40. HE J, Liu X, Duan S, Ye R, et al
    Untargeted plasma metabolomics reveals extensive metabolic alterations among treatment naive HIV/HCV co-infected patients with liver disease progression.
    AIDS Res Hum Retroviruses. 2022 Apr 6. doi: 10.1089/AID.2021.0123.
    PubMed     Abstract available


    March 2022
  41. RUBIN L, Neijna A, Shi Q, Hoover DR, et al
    Degree of polypharmacy and cognitive function in older women with HIV.
    AIDS Res Hum Retroviruses. 2022 Mar 31. doi: 10.1089/AID.2021.0231.
    PubMed     Abstract available


  42. RUIZ-ALGUERO M, Alejos B, Garcia Yubero C, Riera Jaume M, et al
    Use of generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection in Spain.
    AIDS Res Hum Retroviruses. 2022 Mar 31. doi: 10.1089/AID.2021.0122.
    PubMed     Abstract available


  43. SANGARLANGKARN A, Apornpong T, Woodard J, Jordan A, et al
    Correlation Between Polypharmacy and Frailty Among Thai Older Persons Living with HIV.
    AIDS Res Hum Retroviruses. 2022 Mar 24. doi: 10.1089/AID.2021.0214.
    PubMed     Abstract available


  44. DUBE K, Eskaf S, Barr L, Palm D, et al
    Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause (IMAP) in the United States: Results from the AIDS Clinical Trials Group (ACTG) A5345 Biomarker Study.
    AIDS Res Hum Retroviruses. 2022 Mar 24. doi: 10.1089/AID.2021.0170.
    PubMed     Abstract available


  45. KOAY WLA, Xiao J, Temprosa M, Happ LP, et al
    Outcomes of Dual Versus Triple Antiretroviral Drug Regimens Among Virally Suppressed Adults in the DC Cohort.
    AIDS Res Hum Retroviruses. 2022 Mar 23. doi: 10.1089/aid.2021.0202.
    PubMed     Abstract available


  46. BOWMAN E, Wilson M, Riedl K, MaWhinney S, et al
    Lipidome alterations with exercise among people with and without HIV- an exploratory study.
    AIDS Res Hum Retroviruses. 2022 Mar 18. doi: 10.1089/AID.2021.0154.
    PubMed     Abstract available


  47. KARUNAIANANTHAM R, Nesakumar M, Gopalan B, Haribabu H, et al
    Molecular characterisation of the pol gene of vertically transmitted HIV-1 strains in children with virological failure.
    AIDS Res Hum Retroviruses. 2022 Mar 18. doi: 10.1089/AID.2021.0227.
    PubMed     Abstract available


  48. HARNPARIPHAN W, Han WM, Supanan R, Ubolyam S, et al
    High proportion of blood-borne and sexually transmitted infections among people deprived of liberty in a central male prison in Thailand: a cross-sectional study 2018-2019.
    AIDS Res Hum Retroviruses. 2022 Mar 9. doi: 10.1089/AID.2021.0134.
    PubMed     Abstract available


  49. MCLIGEYO A, Wekesa P, Owuor K, Mwangi J, et al
    Factors associated with treatment outcomes among children and adolescents living with HIIV receiving antiretroviral therapy in central Kenya.
    AIDS Res Hum Retroviruses. 2022 Mar 1. doi: 10.1089/AID.2021.0112.
    PubMed     Abstract available


  50. WEI Q, Zhao Y, Lv Y, Kang X, et al
    High rate of HIV-1 drug resistance in ART-failure patients in Liaoning Province, China.
    AIDS Res Hum Retroviruses. 2022 Mar 1. doi: 10.1089/AID.2021.0079.
    PubMed     Abstract available


    February 2022
  51. BURNS CM, Borges M, Frye J, Keicher K, et al
    Understanding Retention in PrEP Care in the South: Insights from an Academic HIV Prevention Clinic.
    AIDS Res Hum Retroviruses. 2022 Feb 16. doi: 10.1089/AID.2021.0177.
    PubMed     Abstract available


  52. TARAMASSO L, Lo Caputo S, Magnasco L, Briano F, et al
    Long-term effectiveness of rilpivirine-based single-tablet regimens in a seven-year two centers observational cohort of people living with HIV.
    AIDS Res Hum Retroviruses. 2022 Feb 16. doi: 10.1089/AID.2021.0161.
    PubMed     Abstract available


  53. LI Y, Zhu B, Han J, Li J, et al
    Identification of Two Novel HIV-1 unique Recombinant Forms in Shenzhen, China.
    AIDS Res Hum Retroviruses. 2022 Feb 16. doi: 10.1089/AID.2021.0229.
    PubMed     Abstract available


  54. KETELS T, Gisolf J, Claassen M, Swanink C, et al
    Prolonged COVID-19 infection in a patient with newly diagnosed HIV/AIDS.
    AIDS Res Hum Retroviruses. 2022 Feb 16. doi: 10.1089/AID.2021.0145.
    PubMed     Abstract available


  55. ALMOMEN A, Cox J, Lebouche B, Cheng M, et al
    Ongoing impact of the social determinants of health during the second and third waves of the COVID-19 pandemic in People Living with HIV receiving care in a Montreal-based Tertiary Care Centre.
    AIDS Res Hum Retroviruses. 2022 Feb 16. doi: 10.1089/AID.2021.0186.
    PubMed     Abstract available


  56. FULLER D, O'Connor MA
    Letter to the Editor on Guerriero et al.: Prior infection with coccidioidomycosis in nonhuman primates and impact on SIV disease and vaccine immunogenicity.
    AIDS Res Hum Retroviruses. 2022 Feb 16. doi: 10.1089/AID.2021.0236.
    PubMed     Abstract available


  57. SPENCE AB, Liu C, Rubin L, Aouizerat B, et al
    Class-based antiretroviral exposure and cognition among women living with HIV (WLWH).
    AIDS Res Hum Retroviruses. 2022 Feb 2. doi: 10.1089/AID.2021.0097.
    PubMed     Abstract available


  58. FAN W, Su M, Meng J, Yang X, et al
    Characterization of a New HIV-1 CRF01_AE/B Recombinant Virus Form Among Men Who Have Sex with Men inBaoding, Hebei,China.
    AIDS Res Hum Retroviruses. 2022 Feb 2. doi: 10.1089/AID.2021.0209.
    PubMed     Abstract available


    January 2022
  59. OGUARIRI RM, Brann TW, Adelsberger JW, Chen Q, et al
    S100A8 and S100A9, biomarkers of SARS-CoV-2-infection and other diseases, suppress HIV replication in primary macrophages.
    AIDS Res Hum Retroviruses. 2022 Jan 19. doi: 10.1089/AID.2021.0193.
    PubMed     Abstract available


  60. ZHU B, Zhao J, Wang X, Li H, et al
    Characterization of three Novel HIV-1 Second-Generation Recombinants (CRF01_AE/CRF07_BC) Identified in Shenzhen, China.
    AIDS Res Hum Retroviruses. 2022 Jan 19. doi: 10.1089/AID.2021.0211.
    PubMed     Abstract available


  61. WELLS J, Bai J, Tsementzi D, Jhaney CI, et al
    Exploring the Anal Microbiome in HIV positive and high risk HIV negative Women.
    AIDS Res Hum Retroviruses. 2022 Jan 19. doi: 10.1089/AID.2020.0245.
    PubMed     Abstract available


  62. ROBERTS C, Creamer EK, Boone CA, Young AT, et al
    Population Representation in HIV Cure Research: A Review of Diversity within HIV Cure Studies based in the United States.
    AIDS Res Hum Retroviruses. 2022 Jan 12. doi: 10.1089/AID.2021.0127.
    PubMed     Abstract available


  63. ABDO M, Wu X, Sharma A, Tassiopoulos K, et al
    Regional Differences in Risk of Recurrent Falls Among Older U.S. Women and Men with HIV in the HIV infection, Aging, and Immune Function Long-Term Observational Study (HAILO).
    AIDS Res Hum Retroviruses. 2022 Jan 12. doi: 10.1089/AID.2021.0162.
    PubMed     Abstract available


    December 2021
  64. MEZOH G, Lutchman N, Worsley C, Gededzha M, et al
    Biomarkers of endothelial dysfunction in Black South African HIV-positive subjects are associated with both high viral load and low CD4 counts.
    AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0052.
    PubMed     Abstract available


  65. MAGNASCO L, Pincino R, Pasculli G, Bouba Y, et al
    Predictors of virological failure among people living with HIV switching from an effective first-line antiretroviral regimen.
    AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0016.
    PubMed     Abstract available


  66. GONZALEZ GUEMBE M, Tisner Pensado Y, Tejerina Picado F, Diez C, et al
    SARS-COV-2 infection in people living with HIV: experience from a tertiary hospital in Madrid.
    AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0159.
    PubMed     Abstract available


  67. TERRY C, Mehta CC, Holloway J, Sheth AN, et al
    Dyspnea and Pulmonary Function Among Participants in the Multicenter AIDS Cohort Study Using Protease Inhibitors: A Cross-Sectional Study.
    AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0082.
    PubMed     Abstract available


  68. TURIN CG, Khanjee N, Breaux K, Armamento-Villareal R, et al
    Evaluation of Adherence to Guideline-Based Bone Mineral Density Screening in Veterans with HIV.
    AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0095.
    PubMed     Abstract available


  69. SHERRILL-MIX S, Yang M, Aldrovandi GM, Brenchley J, et al
    A summary of the sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment.
    AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0173.
    PubMed     Abstract available


  70. HAWLEY I, Song M, Scheckter R, McClure T, et al
    Users' Preferred Characteristics of Vaginal Rings for HIV Prevention: A Qualitative Analysis of Two Phase I Trials.
    AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0077.
    PubMed     Abstract available


  71. BONJOCH A, de Cabo F, Puig J, Perez-Alvarez N, et al
    Ultrasound-Based Assessment of Preperitoneal Fat as a Surrogate Marker of Cardiovascular Risk: Comparative Study Between People Living With HIV and Controls.
    AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0141.
    PubMed     Abstract available


  72. ASUNDI A, Olson AJ, Jiang W, Varshney SP, et al
    Integrase inhibitor use associated with weight gain in women and incident diabetes mellitus.
    AIDS Res Hum Retroviruses. 2021 Dec 8. doi: 10.1089/AID.2021.0091.
    PubMed     Abstract available


  73. SHIKUMA C, Le T, Phuong TV, Chew GM, et al
    Immunologic Change over 72 Weeks following Raltegravir- vs Efavirenz-based Therapy in HIV/HCV co-infected Individuals in Vietnam.
    AIDS Res Hum Retroviruses. 2021 Dec 3. doi: 10.1089/AID.2021.0076.
    PubMed     Abstract available


  74. GOODMAN A, Patten L, Castillo-Mancilla JR, Zimmer S, et al
    Factors associated with retention and adherence in a comprehensive, diverse HIV Pre-Exposure Prophylaxis (PrEP) clinic.
    AIDS Res Hum Retroviruses. 2021 Dec 3. doi: 10.1089/AID.2021.0130.
    PubMed     Abstract available


  75. PINTO A, Carrera A, Salem H, Thapa K, et al
    Evolution of HIV-1 Surveillance Drug Resistance Mutations Over 10 Years in New South Wales, Australia.
    AIDS Res Hum Retroviruses. 2021;37:897-902.
    PubMed     Abstract available


    November 2021
  76. SABERI P, Campbell C, Lee EY, Guzman J, et al
    Illustrating HIV Cure Research Strategies for the Next Generation of Research Participants: A Research-Community Collaboration.
    AIDS Res Hum Retroviruses. 2021 Nov 15. doi: 10.1089/AID.2021.0149.
    PubMed     Abstract available


  77. SUN-SUSLOW N, Balon E, Montoya JL, Saloner R, et al
    Frailty Syndrome is Associated with Poorer Self-Reported Sleep Quality Among Older Persons with Human Immunodeficiency Virus.
    AIDS Res Hum Retroviruses. 2021 Nov 13. doi: 10.1089/AID.2020.0158.
    PubMed     Abstract available


  78. JENNINGS L, Kellermann T, Spinelli MA, Nkantsu Z, et al
    Drug resistance, rather than low tenofovir levels in blood or urine, is associated with tenofovir, emtricitabine and efavirenz (TEE) failure in resource-limited settings.
    AIDS Res Hum Retroviruses. 2021 Nov 13. doi: 10.1089/AID.2021.0135.
    PubMed     Abstract available


  79. SCHIEFFER RJ, Bryndza Tfaily E, D'Aquila RT, Greene G, et al
    Conjoint Analysis of User Acceptability of Sustained Long-Acting Pre-exposure Prophylaxis (PrEP) for HIV.
    AIDS Res Hum Retroviruses. 2021 Nov 13. doi: 10.1089/AID.2021.0075.
    PubMed     Abstract available


    October 2021
  80. MADYADI A, Dhoro M, Shamu T, Washaya T, et al
    HIV-1 genetic diversity and natural polymorphisms of the integrase gene in integrase inhibitor naive patients in Harare, Zimbabwe.
    AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0084.
    PubMed     Abstract available


  81. FURLER RL, Nixon DF
    HIV-1 Exploits Transitions Between CD4+ T Cell Migration and Activation.
    AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0137.
    PubMed     Abstract available


  82. BROUILLETTE MJ, Koski L, Scott S, Austin-Keiller A, et al
    Factors influencing psychological distress during the COVID-19 pandemic in people aging with HIV.
    AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0024.
    PubMed     Abstract available


  83. HIRANSUTHIKUL A, Chutinet A, Sophonphan J, Ubolyam S, et al
    Incidence and risk factors of ischemic stroke and transient ischemic attack among people living with HIV: a longitudinal cohort study.
    AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0046.
    PubMed     Abstract available


  84. WALLNER J, Beck IA, Panpradist N, Ruth PS, et al
    Rapid, Near Point-of-Care Assay for HLA-B*57:01 Genotype Associated with Severe Hypersensitivity Reaction to Abacavir.
    AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0103.
    PubMed     Abstract available


  85. LAHER F, Richardson SI, Smith P, Sullivan P, et al
    HIV prevention in a time of COVID-19: A report from the HIVR4P // Virtual conference 2021.
    AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0138.
    PubMed     Abstract available


  86. GALAVIZ KI, Shah S, Gutierrez M, Collins LF, et al
    Patient Experiences with Telemedicine for HIV Care during the first COVID-19 Wave in Atlanta, Georgia.
    AIDS Res Hum Retroviruses. 2021 Oct 23. doi: 10.1089/AID.2021.0109.
    PubMed     Abstract available


  87. KURLE S, Kandaswami S, Gadhe S, Patil A, et al
    HIV-1 Drug Resistance among treatment naive Transgenders from India.
    AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0157.
    PubMed     Abstract available


  88. KUSAGAWA S, Tatsumi M, Sakamoto-Umeki Y, Takekawa N, et al
    Nucleotide sequence of HIV-1-positive specimen reference panel for evaluation of HIV in-vitro diagnostics in Japan.
    AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0160.
    PubMed     Abstract available


  89. PEREIRA B, Mazzitelli M, Milinkovic A, Moyle G, et al
    Predictive value of HIV-related versus traditional risk factors for coronary atherosclerosis in people aging with HIV.
    AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0064.
    PubMed     Abstract available


  90. KIERI O, Marrone G, Sonnerborg A, Nowak P, et al
    Incidence, treatment and outcome of HIV-associated hematologic malignancies in people living with HIV in Sweden.
    AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0020.
    PubMed     Abstract available


  91. SNEDECOR SJ
    Short Communication: Prevalence of Transmitted Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors in European and North American Countries Over 20 Years: An Updated Meta-Analysis.
    AIDS Res Hum Retroviruses. 2021;37:751-753.
    PubMed     Abstract available


    September 2021
  92. JIANG JY, Reid E
    Impact of Insurance Status on Outcomes in Individuals with AIDS-Defining Cancers.
    AIDS Res Hum Retroviruses. 2021 Sep 29. doi: 10.1089/AID.2021.0102.
    PubMed     Abstract available


  93. YABAR CA, Vilcarino GF, Espetia S, Lujan F, et al
    Social, epidemiological, and virological characteristics from Peruvian subjects living with HIV-1 / AIDS with different sexual risk behavior.
    AIDS Res Hum Retroviruses. 2021 Sep 25. doi: 10.1089/AID.2021.0067.
    PubMed     Abstract available


  94. GUTHRIE KM, Rosen RK, Guillen M, Ramirez JJ, et al
    Designing dual compartment HIV prevention products: Women's sensory perceptions and experiences of suppositories for rectal and vaginal use.
    AIDS Res Hum Retroviruses. 2021 Sep 21. doi: 10.1089/AID.2021.0038.
    PubMed     Abstract available


  95. SARKAR S, Haberlen S, Post WS, Kelesidis T, et al
    Short Communication: Plasma Lymphocyte Activation Gene 3 and Subclinical Coronary Artery Disease in the Multicenter AIDS Cohort Study.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/aid.2021.0035.
    PubMed     Abstract available


  96. STIRES H, LaMori J, Chow W, Zalewski Z, et al
    Weight Gain and Related Co-Morbidities Following Antiretroviral Initiation in the 2000s: A Systematic Literature Review.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2020.0216.
    PubMed     Abstract available


  97. MCGOWAN IM, Kunjara Na Ayudhya RP, Brand RM, Marzinke MA, et al
    An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine / Tenofovir Disoproxil Fumarate.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2021.0115.
    PubMed     Abstract available


  98. THET D, Siritientong T, Sangarlangkarn A, Mar Su Lwin H, et al
    Deterioration of nutritional status and its negative association with depression among older HIV-infected Asian population: a four-year longitudinal study.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2021.0087.
    PubMed     Abstract available


  99. MCMANUS KA, Schurman E, An Z, Van Hook R, et al
    Patient Perspective of People with HIV who Gained Medicaid through Medicaid Expansion: A Cross-sectional Qualitative Study.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2021.0129.
    PubMed     Abstract available


  100. BOUCHARD A, Bourdeau F, Roger J, Taillefer VT, et al
    Predictive Factors of Detectable Viral Load in HIV Infected Patients.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2021.0106.
    PubMed     Abstract available


  101. ALVES CGB, Assis MS, Maciel ADS, da Silva JC, et al
    Clinical and laboratory profile of people living with HIV/AIDS with oral Kaposi sarcoma.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2020.0311.
    PubMed     Abstract available


  102. CRANSTON RD, Brown E, Bauermeister J, Dunne EF, et al
    A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026).
    AIDS Res Hum Retroviruses. 2021 Sep 9. doi: 10.1089/AID.2021.0071.
    PubMed     Abstract available


  103. AL-KOUATLY HB, Scott R, Makhamreh M, Cunningham G, et al
    Metabolomics in placental tissue from women living with HIV.
    AIDS Res Hum Retroviruses. 2021 Sep 9. doi: 10.1089/AID.2021.0056.
    PubMed     Abstract available


    August 2021
  104. GREENBERG AE, Celentano D, Metzger D, Magnus M, et al
    The Mid-Atlantic Centers for AIDS Research (CFAR) Consortium (MACC): Promoting HIV Science through Regional Collaboration.
    AIDS Res Hum Retroviruses. 2021 Aug 31. doi: 10.1089/AID.2021.0017.
    PubMed     Abstract available


  105. HERNANDEZ-FAVELA CG, Hernandez-Ruiz VA, Bello-Chavola OY, Crabtree-Ramirez B, et al
    Higher Veterans Aging Cohort Study (VACS) 2.0 Index Scores Predicts Functional Decline among Older Adults Living with HIV.
    AIDS Res Hum Retroviruses. 2021 Aug 31. doi: 10.1089/AID.2020.0295.
    PubMed     Abstract available


  106. HAN L, Li H, Wang L, Jia L, et al
    Near Full-Length Genomic Characterization of Two Novel HIV-1 Unique Recombinant Forms (CRF01_AE/CRF07_BC) Among MSM in Shijiazhuang City, Hebei Province, China.
    AIDS Res Hum Retroviruses. 2021 Aug 31. doi: 10.1089/AID.2021.0100.
    PubMed     Abstract available


  107. CHEN YT, Li ZX, Xie YN, Zhao L, et al
    Genetic characterization of a novel HIV-1 second-generation recombinant form originating from CRF86_BC and a unique recombinant form in Yunnan, China.
    AIDS Res Hum Retroviruses. 2021 Aug 31. doi: 10.1089/AID.2021.0121.
    PubMed     Abstract available


  108. CARD CM, Abrenica B, McKinnon LR, Ball TB, et al
    Endothelial cells promote productive HIV infection of resting CD4+ T cells by an integrin-mediated cell adhesion-dependent mechanism.
    AIDS Res Hum Retroviruses. 2021 Aug 31. doi: 10.1089/AID.2021.0034.
    PubMed     Abstract available


  109. ARANCON PARDO A, Moreno Palomino M, Jimenez-Nacher I, Moreno F, et al
    REAL-WORLD EXPERIENCE WITH TWO-DRUG REGIMENS IN HIV-1 INFECTED PATIENTS BEYOND THE INDICATION OF CLINICAL TRIALS: 48 WEEKS RESULTS.
    AIDS Res Hum Retroviruses. 2021 Aug 31. doi: 10.1089/AID.2021.0041.
    PubMed     Abstract available


  110. KAMKWALALA AR, Garg A, Roy U, Matthews A, et al
    Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV & Aging Workshop.
    AIDS Res Hum Retroviruses. 2021 Aug 18. doi: 10.1089/AID.2021.0059.
    PubMed     Abstract available


  111. MCGOWAN IM, Chawki S, Hendrix CW, Anton PA, et al
    A Randomized, Open Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study).
    AIDS Res Hum Retroviruses. 2021 Aug 12. doi: 10.1089/AID.2021.0096.
    PubMed     Abstract available


  112. DOOLAN B, Yeon J, Baker D, Whitfeld M, et al
    Dupilumab therapy for atopic dermatitis in people living with HIV.
    AIDS Res Hum Retroviruses. 2021 Aug 12. doi: 10.1089/AID.2021.0113.
    PubMed     Abstract available


  113. SARKAR S, Haberlen S, Post W, Kelesidis T, et al
    Plasma Lymphocyte Activation Gene 3 and Subclinical Coronary Artery Disease in the Multicenter AIDS Cohort Study.
    AIDS Res Hum Retroviruses. 2021 Aug 12. doi: 10.1089/AID.2021.0035.
    PubMed     Abstract available


    July 2021
  114. WELLER KG, Evans LK, Shinagawa A, Murtagh A, et al
    Missed Testing Opportunities Among HIV-Positive Adults in a Community Emergency Department.
    AIDS Res Hum Retroviruses. 2021 Jul 27. doi: 10.1089/AID.2020.0229.
    PubMed     Abstract available


  115. YAN J, Luo L, Han J, Yan D, et al
    Comparing non-invasive predictors of neurosyphilis among syphilis patients with and without HIV co-infection based on the real-world diagnostic criteria: a single-centre, retrospective cohort study in China.
    AIDS Res Hum Retroviruses. 2021 Jul 27. doi: 10.1089/AID.2021.0085.
    PubMed     Abstract available


  116. PEREIRA B, Mazzitelli M, Milinkovic A, Casley C, et al
    Evaluation of a clinic dedicated to people aging with HIV at Chelsea and Westminster Hospital: results of a 10-year experience.
    AIDS Res Hum Retroviruses. 2021 Jul 16. doi: 10.1089/AID.2021.0083.
    PubMed     Abstract available


  117. KASAHARA T, Imahashi M, Hashiba C, Mori M, et al
    Retrospective analysis of the efficacy of early antiretroviral therapy in HIV-1-infected patients coinfected with Pneumocystis jirovecii.
    AIDS Res Hum Retroviruses. 2021 Jul 8. doi: 10.1089/AID.2021.0025.
    PubMed     Abstract available


    June 2021
  118. YAO Y, Zeng Y, Huang H, Li J, et al
    Characteristics of four novel recombinant strains from the backbone of CRF55_01B and CRF65_cpx in Beijing by near full-length genome.
    AIDS Res Hum Retroviruses. 2021 Jun 24. doi: 10.1089/AID.2020.0255.
    PubMed     Abstract available


  119. WILBOURN B, Saafir-Callaway B, Jair K, Wertheim JO, et al
    Characterization of HIV Risk Behaviors and Clusters Using HIV-TRACE among a Cohort of Persons Living with HIV in Washington, DC.
    AIDS Res Hum Retroviruses. 2021 Jun 22. doi: 10.1089/AID.2021.0031.
    PubMed     Abstract available


  120. QUILES N, Ortiz A
    Prevalence of Cardiometabolic Risk Factors Among People Living with HIV in Southern Texas.
    AIDS Res Hum Retroviruses. 2021 Jun 17. doi: 10.1089/AID.2021.0019.
    PubMed     Abstract available


  121. OGOLA BO, Matume ND, Mavhandu LG, Tebit DM, et al
    Drug resistance mutations in a population prior to antiretroviral therapy initiation in Northern South Africa.
    AIDS Res Hum Retroviruses. 2021 Jun 9. doi: 10.1089/AID.2021.0026.
    PubMed     Abstract available


  122. CAPOFERRI AA, Redd AD, Gocke CD, Clark LR, et al
    Persistence of HIV after allogeneic bone marrow transplant in a dually-infected individual.
    AIDS Res Hum Retroviruses. 2021 Jun 9. doi: 10.1089/AID.2021.0047.
    PubMed     Abstract available


  123. HOU Z, Tan J, Jiang Y, Zhang L, et al
    Characterization and Recombinant genotypes of HIV-1 in Gansu Province, China.
    AIDS Res Hum Retroviruses. 2021 Jun 9. doi: 10.1089/AID.2021.0008.
    PubMed     Abstract available


  124. DE MENDOZA C, Caballero E, Eiros JM, Rojo S, et al
    Impact of COVID-19 on Case Reporting for HTLV and HIV-2 in Spain.
    AIDS Res Hum Retroviruses. 2021 Jun 3. doi: 10.1089/AID.2021.0013.
    PubMed     Abstract available


  125. CALEB-ADEPOJU SO, Dawit R, Gbadamosi SO, Sheehan DM, et al
    Factors Associated with Viral Suppression among Racial/Ethnic Minority Women in the Miami-Dade County Ryan White Program, 2017.
    AIDS Res Hum Retroviruses. 2021 Jun 3. doi: 10.1089/AID.2021.0039.
    PubMed     Abstract available


  126. OLUSOLA FI, Olusola BA, Oladokun R, Falade CO, et al
    SURVEILLANCE OF PRE-TREATMENT DRUG RESISTANCE AMONG HIV INFECTED CHILDREN IN IBADAN, OYO STATE, NIGERIA.
    AIDS Res Hum Retroviruses. 2021 Jun 2. doi: 10.1089/AID.2020.0272.
    PubMed     Abstract available



  127. Retraction of: Human Immunodeficiency Virus (HIV) and Outcomes from Coronavirus Disease 2019 (COVID-19) Pneumonia: A Meta-Analysis and Meta-Regression (doi: 10.1089/aid.2020.0307).
    AIDS Res Hum Retroviruses. 2021;37:503.
    PubMed    


    May 2021
  128. OLIVEIRA RC, Graf T, Rego FFA, Silva GPSA, et al
    Dynamic dispersion of HIV-1 Subtype C towards Brazilian northeastern region.
    AIDS Res Hum Retroviruses. 2021 May 26. doi: 10.1089/AID.2020.0308.
    PubMed     Abstract available


  129. MAYER S, Rayeed N, Novak RM, Li J, et al
    INSTI-BASED INITIAL ANTIRETROVIRAL THERAPY IN ADULTS WITH HIV, THE HIV OUTPATIENT STUDY, 2007-2018.
    AIDS Res Hum Retroviruses. 2021 May 25. doi: 10.1089/AID.2020.0286.
    PubMed     Abstract available


  130. DE PAZ-SILAVA SLM, Victoriano-Belvis AFB, Gloriani NG, Hibi Y, et al
    In vitro antiviral activity of Mentha cordifolia plant extract in HIV-1 latently infected cells using an established human cell line.
    AIDS Res Hum Retroviruses. 2021 May 25. doi: 10.1089/AID.2021.0053.
    PubMed     Abstract available


  131. NG QR, Tee KK, Binley JM, Tong T, et al
    Cross-neutralizing CRF01_AE-infected Plasma from Malaysia Targets CD4-binding Site of Human Immunodeficiency Virus Type-1 (HIV-1) Envelope Glycoprotein.
    AIDS Res Hum Retroviruses. 2021 May 18. doi: 10.1089/AID.2020.0299.
    PubMed     Abstract available


  132. HIRANSUTHIKUL A, Chutinet A, Suwanwela N
    Ischemic stroke subtypes among Thai HIV-infected patients: a 12-year retrospective study.
    AIDS Res Hum Retroviruses. 2021 May 18. doi: 10.1089/AID.2021.0003.
    PubMed     Abstract available


  133. MOUNZER K, Brunet L, Hsu R, Fusco JS, et al
    Changes in BMI associated with antiretroviral regimen switch among treatment-experienced, virologically suppressed people living with HIV in the United States.
    AIDS Res Hum Retroviruses. 2021 May 18. doi: 10.1089/AID.2020.0287.
    PubMed     Abstract available


  134. LATINI A, Dona MG, Giuliani M, Ancona C, et al
    HIV viral load trends during the COVID-19 pandemic in a reference center for HIV in Rome, Italy.
    AIDS Res Hum Retroviruses. 2021 May 8. doi: 10.1089/AID.2021.0044.
    PubMed     Abstract available


  135. MILLER ES, Garcia PM, Sutton SH, Jackson J, et al
    Getting to Zero: A Demonstration Project of Partner HIV Testing in the Prenatal Setting in Chicago, Illinois.
    AIDS Res Hum Retroviruses. 2021 May 7. doi: 10.1089/aid.2020.0122.
    PubMed     Abstract available


  136. KLEINMAN A, Sivanandham R, Sette P, Brocca-Cofano E, et al
    Lack of Specific Regulatory T-Cell Depletion and Cytoreduction Associated with Extensive Toxicity after Administration of Low and High Doses of Cyclophosphamide.
    AIDS Res Hum Retroviruses. 2021 May 6. doi: 10.1089/AID.2021.0036.
    PubMed     Abstract available


  137. DUBE K, Kanazawa JT, Campbell C, Boone CA, et al
    Considerations for Increasing Racial, Ethnic, Gender and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.
    AIDS Res Hum Retroviruses. 2021 May 5. doi: 10.1089/AID.2021.0023.
    PubMed     Abstract available


    April 2021
  138. XING Y, Guo Y, Wang L, Li H, et al
    Identification of two Novel HIV-1 Second-generation Recombinant Forms (CRF01_AE/CRF07_BC) in Hebei, China.
    AIDS Res Hum Retroviruses. 2021 Apr 30. doi: 10.1089/AID.2021.0057.
    PubMed     Abstract available


  139. WANG L, Shao C, Lu L, Liu J, et al
    A longitudinal case study of concurrent infection with Syphilis and HIV during the early phase.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2020.0281.
    PubMed     Abstract available


  140. ROMANO JW, Baum M, Demkovich ZR, Diana F, et al
    Tenofovir Alafenamide (TAF) for HIV Prevention: Review of the Proceedings from the Gates Foundation Long Acting (LA) TAF Product Development Meeting.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2021.0028.
    PubMed     Abstract available


  141. YE DQ, Ashuro AA, Fan YG, Fu YS, et al
    The Effect of Rosuvastatin on plasma/serum levels of high sensitivity C-reactive protein, Interleukin-6 and D-dimer in people living with Human Immunodeficiency Virus: a systematic review and meta-analysis.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2020.0273.
    PubMed     Abstract available


  142. PUJARI S, Gaikwad S, Chitalikar A, Dabhade D, et al
    CORONAVIRUS DISEASE 19 AMONGST PEOPLE LIVING WITH HIV IN WESTERN INDIA: AN OBSERVATIONAL COHORT STUDY.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2021.0004.
    PubMed     Abstract available


  143. IBRAHIM ME, Glidden DV, Grant RM, Anderson PL, et al
    Revisiting the Pharmacological Forgiveness of HIV Pre-Exposure Prophylaxis.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2021.0032.
    PubMed     Abstract available


  144. SIYAN C, Qihua X, Jian W, Xinghua T, et al
    Effects of artesunate tablet on immune activation and reconstitution among HAART-treated patients with incomplete immune responses.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2020.0254.
    PubMed     Abstract available


  145. KOECH E, Stafford KA, Mutysia I, Katana A, et al
    Factors Associated with Loss to Follow-up among Patients Receiving HIV Treatment in Nairobi, Kenya.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2020.0292.
    PubMed     Abstract available


  146. VIZCARRA P, Cabello A, Moreno A, Vivancos MJ, et al
    Progression risk in people with HIV and COVID-19: Predictive performance of current risk scores.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2021.0012.
    PubMed     Abstract available


  147. BECKWITH C, Min S, Manne A, Novitsky V, et al
    HIV drug resistance and transmission networks among a justice-involved population at the time of community re-entry in Washington D.C.
    AIDS Res Hum Retroviruses. 2021 Apr 25. doi: 10.1089/AID.2020.0267.
    PubMed     Abstract available


  148. SHERMAN KE, Kottilil S, Rouster SD, Abdel-Hameed EA, et al
    Hepatitis E Infection in a Longitudinal Cohort of HCV and HCV/HIV Coinfected Persons.
    AIDS Res Hum Retroviruses. 2021 Apr 1. doi: 10.1089/AID.2020.0303.
    PubMed     Abstract available


    March 2021
  149. DILLON SM, Abdo MH, Wilson MP, Liu J, et al
    A Unique Gut Microbiome-Physical Function Axis Exists In Older People With HIV: An Exploratory Study.
    AIDS Res Hum Retroviruses. 2021 Mar 31. doi: 10.1089/AID.2020.0283.
    PubMed     Abstract available


  150. RODRIGUEZ-CASTANON JM, McNaugthon A, Cardenas-Ochoa A, Fuentes-Romero LL, et al
    Exceptional T CD4+ recovery post-ART is linked to a lower HIV reservoir with a specific immune differentiation pattern.
    AIDS Res Hum Retroviruses. 2021 Mar 28. doi: 10.1089/AID.2020.0270.
    PubMed     Abstract available


  151. BUCHBINDER MH, Blue C, Brown ME, Bradley-Bull S, et al
    Jail-based Data-to-Care to Improve Continuity of HIV Care: Perspectives and Experiences from Previously Incarcerated Individuals.
    AIDS Res Hum Retroviruses. 2021 Mar 25. doi: 10.1089/AID.2020.0296.
    PubMed     Abstract available


  152. KAMORI D, Hasan Z, Carlson J, Kawana-Tachikawa AI, et al
    Impact of human leukocyte antigen-associated polymorphisms on variability of HIV-1 accessory and regulatory proteins.
    AIDS Res Hum Retroviruses. 2021 Mar 24. doi: 10.1089/AID.2021.0055.
    PubMed     Abstract available


  153. CHENG SW, Chen YP, Qi F, Gao R, et al
    Genetic characterization of a novel HIV-1 second-generation recombinant form (CRF01_AE/07_BC) identified in Yan`an city, China.
    AIDS Res Hum Retroviruses. 2021 Mar 24. doi: 10.1089/AID.2021.0058.
    PubMed     Abstract available


  154. KAPELIOS CJ, Masouris G, Argyris A, Konstantinidis I, et al
    Detection of subclinical coronary artery lesions by Framingham risk score, peripheral artery atheromatosis and coronary artery calcium score: a pilot study in asymptomatic individuals living with HIV.
    AIDS Res Hum Retroviruses. 2021 Mar 22. doi: 10.1089/AID.2021.0015.
    PubMed     Abstract available


  155. MCGOWAN IM, Tzakis N, Kosak B, Korczak B, et al
    Evaluation of the Safety, Acceptability, and Pharmacokinetic Profile of a Gel Formulation of OB-002 in Healthy Volunteers.
    AIDS Res Hum Retroviruses. 2021 Mar 22. doi: 10.1089/AID.2021.0010.
    PubMed     Abstract available


  156. MACDONALD DM, Collins G, Wendt CH, Wolfson J, et al
    A pilot study of the effects of losartan vs. placebo on pneumoproteins in HIV: A secondary analysis of a randomized, double blind, study.
    AIDS Res Hum Retroviruses. 2021 Mar 22. doi: 10.1089/AID.2020.0285.
    PubMed     Abstract available


  157. DAHL CM, Miller ES, Leziak K, Jackson J, et al
    Communication between pregnant women and male partners about HIV testing in the United States.
    AIDS Res Hum Retroviruses. 2021 Mar 19. doi: 10.1089/AID.2020.0300.
    PubMed     Abstract available


  158. HERBERTSON EC, Lahiri C, Nwogu JN, Soremekun RO, et al
    High Acceptability of Donating Hair and other Biological Samples for Research Among People Living with HIV in an Outpatient Clinic in Lagos, Nigeria.
    AIDS Res Hum Retroviruses. 2021 Mar 9. doi: 10.1089/AID.2020.0214.
    PubMed     Abstract available


  159. GALAVIZ KI, Schneider MF, Tien PC, Althoff KN, et al
    Expanding the Finnish Diabetes Risk Score for predicting diabetes incidence in people living with HIV.
    AIDS Res Hum Retroviruses. 2021 Mar 8. doi: 10.1089/AID.2020.0247.
    PubMed     Abstract available


  160. BAILEY AJ, Rhee SY, Shafer RW
    Integrase Strand Transfer Inhibitor Resistance in Integrase Strand Transfer Inhibitor-Naive Persons.
    AIDS Res Hum Retroviruses. 2021 Mar 8. doi: 10.1089/AID.2020.0261.
    PubMed     Abstract available


  161. SABERI P, Campbell C, Venegas M, Dube K, et al
    Time to Engage Young People in HIV Cure Research.
    AIDS Res Hum Retroviruses. 2021 Mar 7. doi: 10.1089/AID.2020.0268.
    PubMed     Abstract available


  162. RUDOMETOVA NB, Shcherbakova NS, Shcherbakov DN, Mishenova EV, et al
    Genetic diversity and drug resistance mutations in reverse transcriptase and protease genes of HIV-1 isolates from Southwestern Siberia.
    AIDS Res Hum Retroviruses. 2021 Mar 7. doi: 10.1089/AID.2020.0225.
    PubMed     Abstract available


  163. LOFGREN SM, Nicol MR, Kandole TK, Castillo-Mancilla JR, et al
    A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal Meningitis.
    AIDS Res Hum Retroviruses. 2021 Mar 7. doi: 10.1089/AID.2020.0202.
    PubMed     Abstract available


  164. GUAN Y, Bai D, Wang C, Liu Y, et al
    Mycobacterium kansasii Infection Presenting as an Invasive Endobronchial Occupancy.
    AIDS Res Hum Retroviruses. 2021;37:171-172.
    PubMed    


    February 2021
  165. JONES DL, Rodriguez VJ, Salazar AS, Montgomerie E, et al
    Sex Differences in the Association Between Stress, Loneliness, and COVID-19 Burden among People with HIV in the US.
    AIDS Res Hum Retroviruses. 2021 Feb 25. doi: 10.1089/AID.2020.0289.
    PubMed     Abstract available


  166. MILIC J, Novella A, Meschiari M, Menozzi M, et al
    Darunavir/cobicistat is associated with negative outcomes in HIV-negative patients with severe COVID-19 pneumonia.
    AIDS Res Hum Retroviruses. 2021 Feb 23. doi: 10.1089/AID.2020.0305.
    PubMed     Abstract available


  167. SMITH K
    Long-acting injectables come of age to change the HIV therapeutic landscape and the lives of persons with HIV.
    AIDS Res Hum Retroviruses. 2021 Feb 19. doi: 10.1089/AID.2021.0037.
    PubMed     Abstract available


  168. PATEL RH, Acharya A, Chand HS, Mohan M, et al
    HIV and SARS-CoV-2 Co-infection: A Systematic Review of the Literature and Challenges.
    AIDS Res Hum Retroviruses. 2021 Feb 18. doi: 10.1089/AID.2020.0284.
    PubMed     Abstract available


  169. DA SILVA AS, Cavalcanti MDSM, Belmont TFM, Ximenes RAA, et al
    The 1G/1G + 1G/2G genotypes of MMP1 rs1799750 are associated with higher levels of MMP-1 and are both associated with lipodystrophy in people living with HIV on antiretroviral therapy?
    AIDS Res Hum Retroviruses. 2021 Feb 15. doi: 10.1089/AID.2020.0237.
    PubMed     Abstract available


  170. MONTANO M
    PRESSING QUESTIONS AND CHALLENGES IN THE HIV-1 AND SARS-COV-2 SYNDEMIC.
    AIDS Res Hum Retroviruses. 2021 Feb 15. doi: 10.1089/AID.2021.0005.
    PubMed     Abstract available


  171. CICCULLO A, Baldin G, Dusina A, Cossu MV, et al
    Efficacy and safety of dolutegravir plus lamivudine as a first-line regimen in clinical practice.
    AIDS Res Hum Retroviruses. 2021 Feb 15. doi: 10.1089/AID.2020.0276.
    PubMed     Abstract available


  172. WEERASURIA M, Ko C, Ehm A, O'Bryan J, et al
    The impact of the COVID-19 pandemic on people living with HIV in Victoria, Australia.
    AIDS Res Hum Retroviruses. 2021 Feb 15. doi: 10.1089/AID.2021.0007.
    PubMed     Abstract available


  173. TROYANO-HERNAEZ P, Reinosa R, Burgos MC, Holguin A, et al
    Update in natural antiretroviral-associated mutations among HIV-2 variants and discrepancies across HIV-2 resistance interpretation tools.
    AIDS Res Hum Retroviruses. 2021 Feb 15. doi: 10.1089/AID.2020.0180.
    PubMed     Abstract available


  174. CICCULLO A, Baldin G, Borghi V, Lassandro AP, et al
    Lamivudine plus dolutegravir improves bone mineral density compared to emtricitabine/tenofovir alafenamide plus an integrase inhibitor.
    AIDS Res Hum Retroviruses. 2021 Feb 15. doi: 10.1089/AID.2020.0274.
    PubMed     Abstract available


  175. YORK L, Fisher JM, Malladi L, August JA, et al
    Antiretroviral Laboratory Monitoring and Implications for HIV Clinical Care in the Era of COVID-19 and Beyond.
    AIDS Res Hum Retroviruses. 2021 Feb 10. doi: 10.1089/AID.2020.0263.
    PubMed     Abstract available


  176. HU M, Valicherla GR, Zhou T, Hillier SL, et al
    Expression, activity, and regulation of phosphorylating enzymes in tissues and cells relevant to HIV-1 sexual transmission.
    AIDS Res Hum Retroviruses. 2021 Feb 10. doi: 10.1089/AID.2020.0250.
    PubMed     Abstract available


    January 2021
  177. HARIYANTO TI, Putri C, Frinka P, Louisa J, et al
    Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression.
    AIDS Res Hum Retroviruses. 2021 Jan 27. doi: 10.1089/AID.2020.0307.
    PubMed     Abstract available


  178. GALIWANGO RM, Ssuuna C, Kaleebu P, Kigozi G, et al
    Validation of the Asante HIV-1 Rapid Recency(R) Assay for detection of recent HIV-1 infections in Uganda.
    AIDS Res Hum Retroviruses. 2021 Jan 27. doi: 10.1089/AID.2020.0279.
    PubMed     Abstract available


  179. CHAWANA TD, Nhachi CFB, Nathoo K, Ngara B, et al
    Higher tenofovir concentrations in hair are associated with decreases in viral load and not self-reported adherence in HIV-infected adolescents with second line virological treatment failure.
    AIDS Res Hum Retroviruses. 2021 Jan 26. doi: 10.1089/AID.2020.0258.
    PubMed     Abstract available


  180. DEVANATHAN AS, Kashuba A
    HIV Persistence in the Spleen: Opportunities for Pharmacologic Intervention.
    AIDS Res Hum Retroviruses. 2021 Jan 26. doi: 10.1089/AID.2020.0266.
    PubMed     Abstract available


  181. DI CARLO D, Falasca F, Palermo E, Mezzaroma I, et al
    Dolutegravir-based regimen for maintenance of viral suppression in people living with HIV: 48-week results in real life setting.
    AIDS Res Hum Retroviruses. 2021 Jan 24. doi: 10.1089/AID.2020.0196.
    PubMed     Abstract available


  182. DIEPSTRA KL, Barr L, Palm D, Hogg E, et al
    Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause (IMAP): Results from the AIDS Clinical Trials Group (ACTG) A5345 Biomarker Study.
    AIDS Res Hum Retroviruses. 2021 Jan 20. doi: 10.1089/AID.2020.0222.
    PubMed     Abstract available


  183. ROSSOUW J, Schwartz S, Rao A, Mcingana M, et al
    Exploring the association between depression and social and bio-behavioural HIV risks factors among female sex workers in Nelson Mandela Bay Municipality, South Africa.
    AIDS Res Hum Retroviruses. 2021 Jan 20. doi: 10.1089/AID.2020.0233.
    PubMed     Abstract available


  184. RUHANYA V, Jacobs GB, Naidoo S, Paul RH, et al
    Impact of plasma IP-10/CXCL10 and RANTES/CCL5 levels on neurocognitive function in HIV treatment naive patients.
    AIDS Res Hum Retroviruses. 2021 Jan 20. doi: 10.1089/AID.2020.0203.
    PubMed     Abstract available


  185. HAALAND R, Martin A, Mengesha M, Dinh C, et al
    Evaluation of antiretroviral drug concentrations in minimally invasive specimens for potential development of point of care drug assays.
    AIDS Res Hum Retroviruses. 2021 Jan 18. doi: 10.1089/AID.2020.0187.
    PubMed     Abstract available


  186. MIRANDA AC, Miranda M, Pingarilho M, Pimentel V, et al
    Determinants of HIV-1 late presentation in a cohort of Portuguese HIV-1 patients.
    AIDS Res Hum Retroviruses. 2021 Jan 18. doi: 10.1089/AID.2020.0175.
    PubMed     Abstract available


  187. BERARD AR, Miller C, Arainga M, Broedlow CA, et al
    SIV susceptibility, immunology and microbiome in the female genital tract of adolescent versus adult pigtail macaques.
    AIDS Res Hum Retroviruses. 2021 Jan 15. doi: 10.1089/AID.2020.0271.
    PubMed     Abstract available


  188. LI J, Gao L, Ye Z
    Study of Brain Structure in HIV Vertically Infected Adolescents.
    AIDS Res Hum Retroviruses. 2021 Jan 11. doi: 10.1089/AID.2020.0030.
    PubMed     Abstract available


  189. KOUAMOU V, Mavetera J, Manasa J, Ndhlovu CE, et al
    Pre-treatment HIV Drug Resistance Among Adults Initiating or Re-initiating 1st Line Antiretroviral Therapy in Zimbabwe: Fast-tracking the Transition to Dolutegravir Based 1st Line Regimens?
    AIDS Res Hum Retroviruses. 2021 Jan 11. doi: 10.1089/AID.2020.0242.
    PubMed     Abstract available


  190. BARIK SK, Bansal AK, Mohanty PS, Tripathy SP, et al
    Detection of drug resistance mutations in the reverse transcriptase gene of HIV-1-infected North Indian population failing first line antiretroviral therapy "A follow-up cohort study".
    AIDS Res Hum Retroviruses. 2021 Jan 3. doi: 10.1089/AID.2020.0132.
    PubMed     Abstract available


  191. WANG X, Zhang Y, Liu Y, Li H, et al
    Phylogenetic analysis of sequences in the HIV database revealed multiple potential circulating recombinant forms in China.
    AIDS Res Hum Retroviruses. 2021 Jan 3. doi: 10.1089/AID.2020.0190.
    PubMed     Abstract available


  192. NGALAMIKA O, Munsaka S, Lidenge S, West J, et al
    Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-related, and Sociodemographic Predictors of Outcome.
    AIDS Res Hum Retroviruses. 2021 Jan 1. doi: 10.1089/AID.2020.0099.
    PubMed     Abstract available


  193. ZHAO R, Ding R, Zhang Q
    What are the risk factors for surgical site infection in HIV positive patients receiving open reduction and internal fixation of traumatic limb fractures? A retrospective cohort study.
    AIDS Res Hum Retroviruses. 2021 Jan 1. doi: 10.1089/AID.2020.0184.
    PubMed     Abstract available


    December 2020
  194. AL-KHOUJA A, Shieh EC, Fuchs EJ, Marzinke MA, et al
    Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: a First-in-Human Study.
    AIDS Res Hum Retroviruses. 2020 Dec 28. doi: 10.1089/AID.2020.0188.
    PubMed     Abstract available


  195. GUERRIERO KA, Murnane RD, Lewis TB, Brown B, et al
    Recrudescence of Natural Coccidioidomycosis during Combination Antiretroviral Therapy in a Pigtail Macaque Experimentally Infected with Simian Immunodeficiency Virus.
    AIDS Res Hum Retroviruses. 2020 Dec 23. doi: 10.1089/AID.2020.0228.
    PubMed     Abstract available


  196. MONTANO-CASTELLON I, Zeballos D, Gutierrez-Peredo G, Netto EM, et al
    "High prevalence of frailty and pre-frailty status in Brazilian patients living with HIV".
    AIDS Res Hum Retroviruses. 2020 Dec 22. doi: 10.1089/AID.2020.0113.
    PubMed     Abstract available


  197. RAGONNET-CRONIN M, Benbow N, Hayford C, Poortinga K, et al
    Sorting by race/ethnicity across HIV genetic transmission networks in three major metropolitan areas in the United States.
    AIDS Res Hum Retroviruses. 2020 Dec 21. doi: 10.1089/AID.2020.0145.
    PubMed     Abstract available


  198. KERRIGAN D, Murray M, Sanchez Karver T, Mantsios A, et al
    Feasibility of implementing long-acting injectable anti-retroviral therapy to treat HIV: a survey of health providers from the 13 countries participating in the ATLAS-2M trial.
    AIDS Res Hum Retroviruses. 2020 Dec 15. doi: 10.1089/AID.2020.0208.
    PubMed     Abstract available


  199. SIM JH, Sherman JB, Stanley TL, Corey KE, et al
    Pro-inflammatory Interleukin-18 is Associated with Hepatic Steatosis and Elevated Liver Enzymes in People with HIV Monoinfection.
    AIDS Res Hum Retroviruses. 2020 Dec 15. doi: 10.1089/AID.2020.0177.
    PubMed     Abstract available


  200. PAPASAVVAS E, Azzoni L, Pagliuzza A, Abdel-Mohsen M, et al
    Safety, immune and anti-viral effects of pegylated interferon alpha 2b administration in ART-suppressed individuals: Results of pilot clinical trial.
    AIDS Res Hum Retroviruses. 2020 Dec 15. doi: 10.1089/AID.2020.0243.
    PubMed     Abstract available


  201. BORGHETTI A, Bellino S, Lombardi F, Whalen M, et al
    Risk of tumour onset in HIV+ patients on two-drug regimens: a cohort study in an Italian hospital.
    AIDS Res Hum Retroviruses. 2020 Dec 15. doi: 10.1089/AID.2020.0087.
    PubMed     Abstract available


  202. MEHTA G, Sharma A, Arora SK
    Acquisition of additional NFkappaB binding sites in LTR of genetically evolving HIV-1 subtype C viral species in host with co-morbidities.
    AIDS Res Hum Retroviruses. 2020 Dec 14. doi: 10.1089/AID.2020.0195.
    PubMed     Abstract available


  203. BEHRENS N, Love M, Bandlamuri M, Bernhardt D, et al
    Characterization of HIV-1 Envelope V3 Region Sequences from Virologically Controlled HIV-Infected Older Patients on Long Term Antiretroviral Therapy.
    AIDS Res Hum Retroviruses. 2020 Dec 7. doi: 10.1089/AID.2020.0139.
    PubMed     Abstract available


  204. XIE YN, Li SL, Yang RR, Huang J, et al
    Genetic characteristics of three unique recombinant forms of HIV-1 in Yunnan, China.
    AIDS Res Hum Retroviruses. 2020 Dec 7. doi: 10.1089/AID.2020.0234.
    PubMed     Abstract available


  205. LAN Y, Li L, Deng X, Cai X, et al
    Near full-length genomic characterization of a novel HIV-1 B/C recombinant form identified in Guangdong Province, China.
    AIDS Res Hum Retroviruses. 2020 Dec 7. doi: 10.1089/AID.2020.0278.
    PubMed     Abstract available


  206. ZHU G, Han J, Li H, Liu Y, et al
    Near full-length Genomic Characterization of 16 HIV-1 CRF01_AE Primary Isolates from Guangxi, China.
    AIDS Res Hum Retroviruses. 2020 Dec 7. doi: 10.1089/AID.2020.0277.
    PubMed     Abstract available


  207. PENG X, Xu Y, Wu N
    Beijing as the hub of CRF07_BC transmission from the intravenous drug users to men who have sex with men in China.
    AIDS Res Hum Retroviruses. 2020 Dec 7. doi: 10.1089/AID.2020.0147.
    PubMed     Abstract available


  208. SNO R, Labadie-Bracho MY, Grunberg MG, Adhin MR, et al
    First Assessment of Acquired HIV-1 Drug Resistance and Mutation Patterns in Suriname.
    AIDS Res Hum Retroviruses. 2020 Dec 7. doi: 10.1089/AID.2020.0194.
    PubMed     Abstract available


  209. BALDIN G, Ciccullo A, Lombardi F, D'Angelillo A, et al
    Comparing lamivudine+dolutegravir and bictegravir/emtricitabine/tenofovir alafenamide as switch strategies: preliminary results from clinical practice.
    AIDS Res Hum Retroviruses. 2020 Dec 5. doi: 10.1089/AID.2020.0219.
    PubMed     Abstract available



  210. Correction to: Systemic Mitochondrial Oxidative Phosphorylation Protein Levels Correlate with Neuroimaging Measures in Chronically HIV-Infected Individuals by Kallianpur KJ, et al. AIDS Res Hum Retroviruses 2020;36(1):83-91 DOI:10.1089/aid.2019.0240.
    AIDS Res Hum Retroviruses. 2020;36:1083.
    PubMed    



  211. Call for Special Issue Papers: Special Issue on Coronaviruses as a Co-Morbidity of HIV Infection.
    AIDS Res Hum Retroviruses. 2020;36:965-966.
    PubMed    


    November 2020
  212. MEHTA G, Sharma A, Arora SK
    Human Immunodeficiency virus-1 (HIV-1) subtype-C genetically diversify to acquire higher replication competence in human host with co-morbid conditions.
    AIDS Res Hum Retroviruses. 2020 Nov 25. doi: 10.1089/AID.2020.0118.
    PubMed     Abstract available


  213. HUSSAIN S, Golozar A, Widney DP, Rappocciolo G, et al
    Effect of statin use on inflammation and immune activation biomarkers in HIV-infected persons on effective anti-retroviral therapy.
    AIDS Res Hum Retroviruses. 2020 Nov 25. doi: 10.1089/AID.2020.0127.
    PubMed     Abstract available


  214. LAHIRI C, Xu Y, Wang K, Alvarez JA, et al
    Weight and body mass index change after switching to integrase inhibitors or tenofovir alafenamide among women living with HIV.
    AIDS Res Hum Retroviruses. 2020 Nov 24. doi: 10.1089/AID.2020.0197.
    PubMed     Abstract available


  215. HAANKUKU UN, Njuho PM
    The estimation of transmitted drug resistance mutation strains probability in the treatment of HIV using the beta-binomial model.
    AIDS Res Hum Retroviruses. 2020 Nov 16. doi: 10.1089/AID.2020.0166.
    PubMed     Abstract available


  216. IBRAHIM ME, Castillo-Mancilla JR, Yager J, Brooks KM, et al
    Individualized Adherence Benchmarks for HIV Pre-Exposure Prophylaxis.
    AIDS Res Hum Retroviruses. 2020 Nov 15. doi: 10.1089/AID.2020.0108.
    PubMed     Abstract available


  217. SENEVIRATNE HK, Tillotson J, Lade JM, Bekker LG, et al
    Metabolism of Long-Acting Rilpivirine Following Intramuscular Injection: HIV Prevention Trials Network Study 076 (HPTN 076).
    AIDS Res Hum Retroviruses. 2020 Nov 15. doi: 10.1089/AID.2020.0155.
    PubMed     Abstract available


  218. PENG X, Xu Y, Huang Y, Zhu B, et al
    Intrapatient Evolutionary Dynamics in an Individual Infected with HIV-1 CRF01_AE Who Experienced Periods of Treatment Failure.
    AIDS Res Hum Retroviruses. 2020 Nov 15. doi: 10.1089/AID.2020.0213.
    PubMed     Abstract available


  219. KANAZAWA JT, Saberi P, Sauceda JA, Dube K, et al
    The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review.
    AIDS Res Hum Retroviruses. 2020 Nov 11. doi: 10.1089/AID.2020.0126.
    PubMed     Abstract available


  220. BABU H, Rachel G, Hanna LE
    Alterations in Circulating Metabolites with Neuroinflammatory Property and Their Impact on Neurological Function in HIV-1-Infected Individuals on Long-Term Suppressive cART.
    AIDS Res Hum Retroviruses. 2020 Nov 10. doi: 10.1089/aid.2020.0218.
    PubMed    


  221. HOPE T
    Call for Special Issue Papers: Special Issue on Coronaviruses as a Co-Morbidity of HIV Infection.
    AIDS Res Hum Retroviruses. 2020;36:i-ii.
    PubMed    


    October 2020
  222. PARKER I, Khalil G, Martin A, Martin MT, et al
    Altered Antibody Responses in Persons Infected with HIV-1 While Using PrEP.
    AIDS Res Hum Retroviruses. 2020 Oct 30. doi: 10.1089/AID.2020.0137.
    PubMed     Abstract available


  223. HADJIKOU A, Pavlopoulou ID, Pantavou K, Georgiou AN, et al
    Drug injection-related norms and high-risk behaviors of people who inject drugs in Athens, Greece.
    AIDS Res Hum Retroviruses. 2020 Oct 30. doi: 10.1089/AID.2020.0050.
    PubMed     Abstract available


  224. CALZA L, Borderi M, Colangeli V, Testi D, et al
    NO SIGNIFICANT CHANGES IN WEIGHT AND BODY FAT MASS IN SUPPRESSED HIV-INFECTED PATIENTS SWITCHED TO DUAL COMBINATION LAMIVUDINE PLUS DOLUTEGRAVIR OR RALTEGRAVIR.
    AIDS Res Hum Retroviruses. 2020 Oct 30. doi: 10.1089/AID.2020.0117.
    PubMed     Abstract available


  225. SRINIVASAN R, Padmapriyadarsini C, Ramesh K, Sanjeeva GN, et al
    APOC3 Gene polymorphism and ART-induced dyslipidemia in HIV Infected Children.
    AIDS Res Hum Retroviruses. 2020 Oct 29. doi: 10.1089/AID.2020.0082.
    PubMed     Abstract available


  226. PAREDES R, Veliz F, Lucchetti AJ
    Comparison of the virological response according to the antiretroviral regimens in Peruvian HIV patients who presented the M184V mutation in two national hospitals during the years 2008 to 2019.
    AIDS Res Hum Retroviruses. 2020 Oct 20. doi: 10.1089/AID.2020.0115.
    PubMed     Abstract available


  227. ADENIYI OV, Obi CL, Goon DT, Iweriebor B, et al
    Genetic Characterization of HIV-1 Subtype A1/C/D/B/K Unique Recombinant Form from Eastern Cape, South Africa.
    AIDS Res Hum Retroviruses. 2020 Oct 20. doi: 10.1089/AID.2020.0160.
    PubMed     Abstract available


  228. GHOSN J, Abdoul H, Fellahi S, Merlet A, et al
    Prevalence of silent atherosclerosis and other comorbidities in an outpatient cohort of adults living with HIV: associations with HIV parameters and biomarkers.
    AIDS Res Hum Retroviruses. 2020 Oct 20. doi: 10.1089/AID.2020.0182.
    PubMed     Abstract available


  229. MEISSNER EG, Chung D, Tsao B, Haas D, et al
    IFNL4 Genotype Does Not Associate with CD4 T-Cell Recovery in Persons Living with HIV.
    AIDS Res Hum Retroviruses. 2020 Oct 16. doi: 10.1089/AID.2020.0104.
    PubMed     Abstract available


  230. JACOBSON D, Liu JZ, Lindsey JC, Shiau S, et al
    Immune markers and their association with bone density in children, adolescents and young adults with perinatally-acquired HIV.
    AIDS Res Hum Retroviruses. 2020 Oct 16. doi: 10.1089/AID.2020.0171.
    PubMed     Abstract available


  231. STAITIEH BS, Auld SC, Ahmed M, Fan X, et al
    GM-CSF Reverses HIV Protein-Induced Mitochondrial Derangements in Alveolar Macrophages.
    AIDS Res Hum Retroviruses. 2020 Oct 15. doi: 10.1089/AID.2020.0176.
    PubMed     Abstract available


  232. HOPE TJ, Klatt NR, Sacha JB, Cannon P, et al
    Timothy Ray Brown: The Serendipitous Hero of HIV Cure Research.
    AIDS Res Hum Retroviruses. 2020 Oct 14. doi: 10.1089/AID.2020.0253.
    PubMed     Abstract available


  233. DIALLO MS, Samri A, Charpentier C, Bertine M, et al
    A comparison of cell activation, exhaustion and expression of HIV co-receptors and restriction factors in HIV-1 and HIV-2 infected Non Progressors.
    AIDS Res Hum Retroviruses. 2020 Oct 14. doi: 10.1089/AID.2020.0084.
    PubMed     Abstract available


  234. DABITAO D, Dembele M, Urbanowski M, Kone B, et al
    Genetic variation in human IL10 proximal promoter and susceptibility to HIV-1 infection in Mali, West Africa.
    AIDS Res Hum Retroviruses. 2020 Oct 12. doi: 10.1089/AID.2020.0140.
    PubMed     Abstract available


  235. HEINSON AI, Woo J, Mukim A, White CH, et al
    Micro RNA targets in HIV latency - insights into novel layers of latency control.
    AIDS Res Hum Retroviruses. 2020 Oct 12. doi: 10.1089/AID.2020.0150.
    PubMed     Abstract available


  236. CHEW G, Padua AJ, Chow D, Souza SA, et al
    Effects of Brief Adjunctive Metformin Therapy in Virologically Suppressed HIV-Infected Adults on Polyfunctional HIV-Specific CD8 T cell Responses to PD-L1 Blockade.
    AIDS Res Hum Retroviruses. 2020 Oct 6. doi: 10.1089/AID.2020.0172.
    PubMed     Abstract available


  237. LOUTFY M, Varriano B, Crouzat F, Sandler I, et al
    Cardiovascular events in an inner-city HIV clinic and relation to abacavir- vs. TDF- containing antiretroviral regimens.
    AIDS Res Hum Retroviruses. 2020 Oct 6. doi: 10.1089/AID.2020.0053.
    PubMed     Abstract available


    September 2020
  238. CICCULLO A, Baldin G, Borghi V, Sterrantino G, et al
    Overall tolerability of Integrase Inhibitors in clinical practice: results from a multicenter Italian cohort.
    AIDS Res Hum Retroviruses. 2020 Sep 30. doi: 10.1089/AID.2020.0078.
    PubMed     Abstract available


  239. ABBAS AL, Marcusso R, Penalva AC, de Almeida VP, et al
    HTLV-1 Versus HIV: 40 years of Challenges from Discovery to Treatment for Human Retroviruses and Neurological Implications.
    AIDS Res Hum Retroviruses. 2020 Sep 30. doi: 10.1089/AID.2020.0210.
    PubMed     Abstract available


  240. WILLIAMS ME, Fielding BC
    Insult to injury- potential contribution of COVID-19 to neuroinflammation and the development of HIV-associated neurocognitive disorders.
    AIDS Res Hum Retroviruses. 2020 Sep 30. doi: 10.1089/AID.2020.0136.
    PubMed     Abstract available


  241. GUTHRIE KM, Fava JL, Vargas S, Rosen RK, et al
    The role of volume in the perceptibility of topical vaginal formulations: User sensory perceptions and experiences (USPEs) of heterosexual couples during vaginal sex.
    AIDS Res Hum Retroviruses. 2020 Sep 29. doi: 10.1089/AID.2020.0138.
    PubMed     Abstract available


  242. HAESELEER F, Eichholz K, Tareen SU, Iwamoto N, et al
    Real-time killing assays to assess the potency of a new anti-SIV CAR.
    AIDS Res Hum Retroviruses. 2020 Sep 29. doi: 10.1089/AID.2020.0163.
    PubMed     Abstract available



  243. Retraction of: Association Between Polymorphisms in the Interleukin-10 Gene and Susceptibility to HIV-1 Infection," by Dan-Hui Fu, Wen-Juan Deng, Zhi Yang, Sen Hong, Qian-Ling Ding, Yang Zhao, Jia Chen, and Dan-Ke Su; AIDS Res Hum Retroviruses, epub:
    AIDS Res Hum Retroviruses. 2020 Sep 28. doi: 10.1089/aid.2020.0011.
    PubMed    


  244. WANG Y, Wen Y
    An AIDS Patient with Recurrent Multiple Skin Crusted Ulcerations.
    AIDS Res Hum Retroviruses. 2020 Sep 28. doi: 10.1089/AID.2020.0212.
    PubMed     Abstract available


  245. YIN Y, Zhou Y, Lu J, Liu X, et al
    Molecular epidemiology of HIV-1 in Jiangsu province, Southeast of China: genotypes and HIV-1 transmission networks among newly diagnosed MSM in 2017.
    AIDS Res Hum Retroviruses. 2020 Sep 24. doi: 10.1089/AID.2020.0165.
    PubMed     Abstract available


  246. HE S, Gao Y, An M, Zhao B, et al
    Characterization of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant Strain among Men Who Have Sex with Men in Liaoning, China.
    AIDS Res Hum Retroviruses. 2020 Sep 24. doi: 10.1089/AID.2020.0223.
    PubMed     Abstract available


  247. TAVARES A, Pingarilho M, Batista J, Viveiros M, et al
    HIV and tuberculosis co-infection among migrants in Portugal: a brief study on their sociodemographic, clinical, and genomic characteristics.
    AIDS Res Hum Retroviruses. 2020 Sep 22. doi: 10.1089/AID.2020.0119.
    PubMed     Abstract available


  248. CHAUDHARY O, Wang L, Bose D, Narayan V, et al
    Comparative evaluation of prophylactic SIV vaccination modalities administered to the oral cavity.
    AIDS Res Hum Retroviruses. 2020 Sep 22. doi: 10.1089/AID.2020.0157.
    PubMed     Abstract available


  249. HARVILLA N, Bhat P, Koka M, Riedel DJ, et al
    Disseminated Mycobacterium avium complex in an HIV-infected with diffuse lymphadenopathy.
    AIDS Res Hum Retroviruses. 2020 Sep 17. doi: 10.1089/AID.2020.0130.
    PubMed     Abstract available


    April 2020
  250. BROWN TR
    The London Patient.
    AIDS Res Hum Retroviruses. 2020;36:251-252.
    PubMed    


  251. GUIMARAES MDC
    Caution on the Interpretation of Respondent-Driven Sampling Results.
    AIDS Res Hum Retroviruses. 2020;36:253.
    PubMed    


    February 2020
  252. AUGIER C, Beyne E, Villabona-Arenas CJ, Mpoudi Ngole E, et al
    Identification of a Novel Simian Immunodeficiency Virus-Infected African Green Monkey (Chlorocebus tantalus) Confirms that Tantalus Monkeys in Cameroon Are Infected with a Mosaic SIVagm Lineage.
    AIDS Res Hum Retroviruses. 2020;36:167-170.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: